Logotype for Genomma Lab Internacional S.A.B. de C.V.

Genomma Lab Internacional (LABB) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Genomma Lab Internacional S.A.B. de C.V.

Q4 2025 earnings summary

26 Feb, 2026

Executive summary

  • 2025 saw a significant deceleration in Mexican consumption and internal execution gaps, leading to a deliberate reduction in sell-in to normalize retailer inventories; like-for-like sales declined 4.3% year-over-year, with Q4 like-for-like sales down 12.9%.

  • Despite the downturn, underlying consumer demand remained resilient, with Q4 Mexico sell-out down only 2.2%.

  • Productivity savings of over MXN 1 billion were unlocked and reinvested in growth initiatives such as product innovation and distribution expansion.

  • EBITDA margin for 2025 was 23.4%, up 43 basis points, reflecting strong cost containment and operational resilience.

  • Management expects early 2026 to show higher OPEX and softer sales, with growth initiatives gaining traction in the second half and a disciplined reset for sustainable growth.

Financial highlights

  • Consolidated net sales for 2025 were MXN 17,541.2 million, down 5.7% year-over-year; Q4 net sales were MXN 4,017.0 million, down 13.9%.

  • Gross profit margin was 62.8% for 2025, down from 64.1% in 2024.

  • Full year EBITDA was MXN 4,100.9 million (23.4% margin), down 4.0% year-over-year; Q4 EBITDA was MXN 886.6 million (22.1% margin), down 16.5%.

  • Full year net income was MXN 1,607.4 million, down 23.1% year-over-year, mainly due to non-cash Forex losses from Argentine peso depreciation.

  • Free cash flow reached MXN 1,507 million, down 45.5% due to higher CapEx, lower net income, and higher tax payments.

Outlook and guidance

  • 2026 guidance: EBITDA margin expected at 23%-23.5%, with a return to 24% in 2027 as operating leverage improves.

  • Q1 2026 expected to be flat or low single-digit growth as inventory normalization completes; gradual top-line recovery anticipated from Q2 onward.

  • CapEx for 2026 projected at MXN 250–270 million, mainly for maintenance and innovation.

  • Cash flow in 2026 expected to improve due to lower CapEx and normalized tax payments.

  • Growth initiatives include product innovation, distribution expansion, enhanced in-store execution, and stronger communication.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more